Eric Honroth leaves Getinge

After twelve years leading Norway's oldest health cluster, Ketil Widerberg is leaving Oslo Cancer Cluster to head an AI initiative in healthcare at Oslo University Hospital.

Alligator Bioscience has appointed its CFO, Johan Giléus, as CEO, effective January 1, 2027. He succeeds Søren Bregenholt, who will remain in the role until the end of the year.

Bavarian Nordic has appointed Tarja Stenvall as President and Chief Executive Officer, effective 15 October. She succeeds Paul Chaplin, whose departure was announced earlier this year.

Over the course of her career, Anna Sundin has worked on numerous transactions spanning capital raises, IPOs, M&A, and debt financing, as well as providing strategic advice to companies in a growth phase.

Danish biotech Initiator Pharma has appointed Annette Säfholm, PhD, as Chief Operating Officer (COO) and a member of the company's management team, strengthening its business development and operational capacity as it approaches topline data from its Phase IIa study of pudafensine in vulvodynia.

AcuCort has appointed Carl Frisk as Strategic Alliance Manager, where he will be responsible for the company's commercial partnerships and the development of its partner network across all markets.

SmiLe Venture Hub is strengthening its board with three new members, bringing perspectives from the global life science industry, Sweden's wider innovation system, and academia.